Berg LLC

Also on record

Records under this name other than the patents Berg LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to Berg LLC

Patent	Title	Status	Expires	Confidence
US 10,588,859	Topical Formulations Having Enhanced Bioavailability now held by Bpgbio, Inc. In force Term ends Mar 21, 2028 · High confidence	In force	Term ends Mar 21, 2028	High confidence
US 10,668,028	Methods and Use of Inducing Apoptosis in Cancer Cells now held by Bpgbio, Inc. In force Term ends Apr 9, 2029 · Medium confidence	In force	Term ends Apr 9, 2029	Medium confidence
US 9,896,731	Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10) now held by Bpgbio, Inc. In force Term ends May 11, 2030 · Medium confidence	In force	Term ends May 11, 2030	Medium confidence
US 10,351,915	Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10) now held by Bpgbio, Inc. In force Term ends May 11, 2030 · Medium confidence	In force	Term ends May 11, 2030	Medium confidence
US 10,519,504	Methods for Treatment of Oncological Disorders Using Epimetabolic Shifters, Multidimensional Intracellular Molecules, or Environmental Influencers now held by Bpgbio, Inc. In force Term ends May 11, 2030 · High confidence	In force	Term ends May 11, 2030	High confidence
US 11,028,446	Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10) now held by Bpgbio, Inc. In force Term ends May 11, 2030 · High confidence	In force	Term ends May 11, 2030	High confidence
US 12,209,285	Methods for Treatment of Oncological Disorders Using an Epimetabolic Shifter (Coenzyme Q10) now held by Bpgbio, Inc. In force Term ends May 11, 2030 · High confidence	In force	Term ends May 11, 2030	High confidence
US 11,305,016	Vitamin D3 and Analogs Thereof for Treating Alopecia now held by Bpgbio, Inc. In force Ends no later than Aug 10, 2030 · Medium confidence	In force	Ends no later than Aug 10, 2030	Medium confidence
US 8,454,945	Topical Formulations Having Enhanced Bioavailability now held by Bpgbio, Inc. In force Term ends Feb 9, 2031 · High confidence	In force	Term ends Feb 9, 2031	High confidence
US 11,400,058	Intravenous Formulations of Coenzyme Q10 (CoQ10) and Methods of Use Thereof now held by Bpgbio, Inc. In force Term ends Mar 11, 2031 · High confidence	In force	Term ends Mar 11, 2031	High confidence

10 of 125 records shown.

Pro members see all 125.

Pro members: see all 125 records